Komori
Haba Laboratories (4925) · PolicySale of strategic shareholdings

Strengthening Relationships through Cross-Shareholdings and Board Verification of Rationality

First written in FY2019. 2 of 4 entries say "Restated". Latest entry: FY2025.

4entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20252019: 120192020: 120202021: 120212022: 020222023: 020232024: 020242025: 12025
Same theme, other companies
Verification of the Rationale for Holding Strategic ShareholdingsA theme 1606 companies write about · 1 as a headwind · 827 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1611 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025Sale of strategic shareholdingsAnnual report

    「During the fiscal year, following a review of its shareholdings, the company sold all of its shares.」

    The company reviewed its cross-shareholdings under its existing policy of verifying the rationality of the holdings and sold all shares it held.
  2. FY2021RestatedAnnual report

    「As a general rule, the company does not hold investment shares for pure investment purposes. With respect to investment shares held for purposes other than pure investment, the company generally holds cross-shareholdings that also serve important group-strategy purposes, such as strengthening relationships.」

    The company continues its policy of generally not holding shares for pure investment purposes, while holding shares for policy purposes, such as strengthening relationships, and verifying the rationality of the holdings through the Board of Directors.
  3. FY2020RestatedAnnual report

    「As a general rule, the company does not hold investment shares for pure investment purposes. With respect to investment shares held for purposes other than pure investment, the company generally holds cross-shareholdings that also serve important group-strategy purposes, such as strengthening relationships.」

    The company continues its policy of generally not holding shares for pure investment purposes, while holding shares for policy purposes, such as strengthening relationships, and verifying the rationality of the holdings through the Board of Directors.
  4. FY2019First statedAnnual report

    「As a general rule, the company does not hold investment shares for pure investment purposes. With respect to investment shares held for purposes other than pure investment, the company generally holds cross-shareholdings that also serve important group-strategy purposes, such as strengthening relationships.」

    The company states a policy of generally not holding shares for pure investment purposes, while holding cross-shareholdings that serve important group-strategy purposes, such as strengthening relationships. It states that the rationality of these holdings will be verified by the Board of Directors.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.